Matinas BioPharma Holdings, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Matinas BioPharma Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Matinas BioPharma Holdings, Inc. Return On Assets for the quarter ending June 30, 2024 was -92.7 %, a 84.6% decline year-over-year.
  • Matinas BioPharma Holdings, Inc. annual Return On Assets for 2023 was -72.2 %, a 72.3% decline from 2022.
  • Matinas BioPharma Holdings, Inc. annual Return On Assets for 2022 was -41.9 %, a 21.7% decline from 2021.
  • Matinas BioPharma Holdings, Inc. annual Return On Assets for 2021 was -34.4 %, a 18.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -72.2 -30.3 -72.3% Jan 1, 2023 Dec 31, 2023
2022 -41.9 -7.46 -21.7% Jan 1, 2022 Dec 31, 2022
2021 -34.4 -5.35 -18.4% Jan 1, 2021 Dec 31, 2021
2020 -29.1 +8.74 +23.1% Jan 1, 2020 Dec 31, 2020
2019 -37.8 +53.2 +58.5% Jan 1, 2019 Dec 31, 2019
2018 -91 -3.5 -4% Jan 1, 2018 Dec 31, 2018
2017 -87.5 +3.39 +3.73% Jan 1, 2017 Dec 31, 2017
2016 -90.9 +0.59 +0.65% Jan 1, 2016 Dec 31, 2016
2015 -91.5 +66.7 +42.2% Jan 1, 2015 Dec 31, 2015
2014 -158 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.